NDC 64578-0074
Tox-Chord
Homeopathic Liquid
Tox-Chord is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Energetix Corp. The primary component is Alfalfa; Aluminum Oxide; Benzoic Acid; D&c Black No. 2; Cetraria Islandica Subsp. Islandica; Estrone; Fucus Vesiculosus; Fumaric Acid; Pork Liver; Potassium Carbonate; Wood Creosote; Sodium Chloride; Paraffin; Kerosene; Phosphoric Acid; Phosphorus; Pine Tar; Plantago Major; Lead; Pulsatilla Vulgaris; Radium Bromide; Resorcinol; Phenyl Salicylate; Silicon Dioxide; Comfrey Root; Tobacco Leaf; Turpentine Oil; Thyroid, Unspecified; Elymus Repens Root; Zinc Oxide.
| Product ID | 64578-0074_4eb7b1f5-fe2d-439b-bc2f-353c72f77c92 |
| NDC | 64578-0074 |
| Product Type | Human Otc Drug |
| Proprietary Name | Tox-Chord |
| Generic Name | Homeopathic Liquid |
| Dosage Form | Liquid |
| Route of Administration | ORAL |
| Marketing Start Date | 2014-10-21 |
| Marketing Category | UNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC |
| Labeler Name | Energetix Corp |
| Substance Name | ALFALFA; ALUMINUM OXIDE; BENZOIC ACID; D&C BLACK NO. 2; CETRARIA ISLANDICA SUBSP. ISLANDICA; ESTRONE; FUCUS VESICULOSUS; FUMARIC ACID; PORK LIVER; POTASSIUM CARBONATE; WOOD CREOSOTE; SODIUM CHLORIDE; PARAFFIN; KEROSENE; PHOSPHORIC ACID; PHOSPHORUS; PINE TAR; PLANTAGO MAJOR; LEAD; PULSATILLA VULGARIS; RADIUM BROMIDE; RESORCINOL; PHENYL SALICYLATE; SILICON DIOXIDE; COMFREY ROOT; TOBACCO LEAF; TURPENTINE OIL; THYROID, UNSPECIFIED; ELYMUS REPENS ROOT; ZINC OXIDE |
| Active Ingredient Strength | 4 [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_C]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL; [hp_X]/59.1mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |